Haemonetics | HAE - Current Liabilities


Haemonetics reported $282.6M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Avanos Medical USD 131.2M 34M Mar/2026
Baxter International USD 3.69B 723M Mar/2026
Becton, Dickinson and Co. USD 8.51B 254M Mar/2026
Boston Scientific USD 4.57B 868M Mar/2026
Cerus USD 100.8M 12.37M Dec/2025
Cooper Companies USD 1.8B 209M Mar/2026
Fresenius EUR 8.38B 1.18B Dec/2025
Fresenius Medical Care EUR 6.73B 484.42M Mar/2026
Globus Medical USD 482.46M 16.04M Mar/2026
Haemonetics USD 282.6M 257.27M Mar/2026
ICU Medical USD 517.9M 19.04M Mar/2026
Intuitive Surgical USD 2.51B 3.2M Mar/2026
Medtronic USD 9.5B 440M Dec/2025
Merit Medical Systems USD 216.87M 22.89M Mar/2026
Neogen USD 150.6M 3.55M Dec/2025
OraSure Technologies USD 44.08M 4.29M Mar/2026
Plus Therapeutics USD 7.96M 4.36M Mar/2026
Quidel USD 962.4M 3.7M Mar/2026
ResMed USD 1.35B 103.1M Mar/2026
STAAR Surgical USD 60.99M 7.51M Mar/2026
Steris USD 1.14B 222.7M Mar/2026
Stryker USD 6.32B 1.48B Mar/2026
Teleflex USD 728.05M 33.98M Mar/2026
Terumo JPY 540.73B 1.03B Mar/2026
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
US Physical Therapy USD 117.3M 21.74M Mar/2026
Zimmer Biomet Holdings USD 2.86B 280.6M Mar/2026